PROF
Income statement / Annual
Last year (2023), Profound Medical Corp.'s total revenue was $7.33 M,
an increase of 9.73% from the previous year.
In 2023, Profound Medical Corp.'s net income was -$28.57 M.
See Profound Medical Corp.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$7.33 M
|
$6.68 M
|
$6.87 M
|
$7.30 M
|
$4.23 M
|
$1.91 M
|
$3.90 M
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$2.82 M |
$3.66 M |
$3.92 M |
$3.83 M |
$1.81 M |
$1.31 M |
$2.41 M |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$4.51 M |
$3.02 M |
$2.95 M |
$3.47 M |
$2.42 M |
$604,815.00 |
$1.49 M |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0.62 |
0.45 |
0.43 |
0.48 |
0.57 |
0.32 |
0.38 |
0 |
0 |
0 |
| Research and Development
Expenses |
$14.38 M
|
$14.69 M
|
$15.28 M
|
$9.91 M
|
$9.54 M
|
$7.54 M
|
$7.66 M
|
$7.43 M
|
$3.70 M
|
$2.31 M
|
| General & Administrative
Expenses |
$9.17 M
|
$9.47 M
|
$10.31 M
|
$7.57 M
|
$5.88 M
|
$4.89 M
|
$4.72 M
|
$4.20 M
|
$4.39 M
|
$1.95 M
|
| Selling & Marketing
Expenses |
$9.45 M
|
$8.47 M
|
$7.65 M
|
$4.86 M
|
$2.14 M
|
$3.00 M
|
$3.12 M
|
$954,120.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$18.62 M
|
$17.93 M
|
$17.97 M
|
$12.43 M
|
$8.01 M
|
$7.89 M
|
$7.84 M
|
$4.20 M
|
$4.39 M
|
$1.95 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$3,755.42 |
$3,646.12 |
$1,569.82 |
$0.00 |
$82,396.00 |
| Operating Expenses |
$33.60 M |
$32.62 M |
$33.24 M |
$22.34 M |
$17.56 M |
$15.43 M |
$15.51 M |
$11.64 M |
$8.09 M |
$4.34 M |
| Cost And Expenses |
$35.82 M |
$36.28 M |
$37.16 M |
$26.17 M |
$19.36 M |
$16.74 M |
$17.92 M |
$11.64 M |
$8.09 M |
$4.34 M |
| Interest Income |
$1.64 M |
$803,000.00 |
$205,000.00 |
$692,000.00 |
$368,460.00 |
$355,196.00 |
$101,576.00 |
$117,251.00 |
$99,236.00 |
$8,527.00 |
| Interest Expense |
$932,798.00 |
$174,000.00 |
$303,000.00 |
$543,000.00 |
$544,748.00 |
$755,374.00 |
$1.07 M |
$615,868.00 |
$4.05 M |
$143,014.00 |
| Depreciation &
Amortization |
$1.15 M
|
$1.60 M
|
$1.88 M
|
$1.54 M
|
$1.51 M
|
$1.23 M
|
$693,310.00
|
$139,132.00
|
$85,772.00
|
$84,896.00
|
| EBITDA |
-$27.12 M
|
-$26.60 M
|
-$28.65 M
|
-$19.50 M
|
-$12.53 M
|
-$13.24 M
|
-$13.23 M
|
-$15.49 M
|
-$11.15 M
|
-$4.25 M
|
| EBITDA Ratio |
-3.7 |
-3.81 |
-4.13 |
-2.28 |
-3.12 |
-6.93 |
-3.39 |
0 |
0 |
0 |
| Operating Income Ratio
|
-3.9
|
-4.43
|
-4.41
|
-2.58
|
-3.58
|
-7.76
|
-4.52
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$607,268.00
|
$3.74 M
|
-$303,000.00
|
-$2.71 M
|
-$171,000.00
|
-$247,725.09
|
$2.24 M
|
-$70,919.00
|
-$1.10 M
|
-$3.60 M
|
| Income Before Tax |
-$29.22 M |
-$28.38 M |
-$30.59 M |
-$21.58 M |
-$15.31 M |
-$15.07 M |
-$14.91 M |
-$12.14 M |
-$12.32 M |
-$7.94 M |
| Income Before Tax Ratio
|
-3.99
|
-4.25
|
-4.45
|
-2.95
|
-3.62
|
-7.89
|
-3.82
|
0
|
0
|
0
|
| Income Tax Expense |
-$130,347.00 |
$287,000.00 |
$105,000.00 |
$45,000.00 |
$148,418.00 |
$169,441.00 |
$58,944.00 |
$10,456.00 |
-$523,222.77 |
$410,407.00 |
| Net Income |
-$28.57 M |
-$28.67 M |
-$30.70 M |
-$21.62 M |
-$15.46 M |
-$15.24 M |
-$14.97 M |
-$12.15 M |
-$11.80 M |
-$8.20 M |
| Net Income Ratio |
-3.9 |
-4.29 |
-4.47 |
-2.96 |
-3.65 |
-7.98 |
-3.84 |
0 |
0 |
0 |
| EPS |
-1.35 |
-1.38 |
-1.5 |
-1.25 |
-1.39 |
-1.52 |
-2.44 |
-2.93 |
-4.98 |
-37.86 |
| EPS Diluted |
-1.35 |
-1.38 |
-1.5 |
-1.25 |
-1.39 |
-1.52 |
-2.44 |
-2.93 |
-4.98 |
-37.86 |
| Weighted Average Shares
Out |
$21.18 M
|
$20.83 M
|
$20.46 M
|
$17.29 M
|
$11.10 M
|
$10.04 M
|
$6.14 M
|
$4.15 M
|
$2.37 M
|
$216,676.00
|
| Weighted Average Shares
Out Diluted |
$21.18 M
|
$20.83 M
|
$20.46 M
|
$17.29 M
|
$11.10 M
|
$10.04 M
|
$6.14 M
|
$4.15 M
|
$2.37 M
|
$216,676.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
